“Allergy Management”的搜索结果，显示 241-250 项，共有 13344 项

1. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the impact of the location of SQ Nivo administration ... treatment and errors will be caught and corrected by the QC ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...

4. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

5. 恢复力训练- 医生与科室- 妙佑医疗国际

   Babic R, et al. Resilience in health and illness. Psychiatria Danubina. 2020; 32:226. Romas JA, et al. Enhancing awareness about managing stress. In: Practical ...

6. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of ...

8. Lipodystrophy syndromes New treatment newer questions - 妙佑医疗国际

   Lipodystrophy syndromes New treatment newer questions. Share; Doximity · Facebook · LinkedIn · Twitter; Print details. MAC-20430366. 医疗专业人员; Lipodystrophy ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficient. Novel ...